Uptake of Hereditary Cancer Screening in a Breast Cancer Survivorship Clinic in the Bronx, New York: A Pilot Study [ID 830]

INTRODUCTION: Breast cancer is the most commonly diagnosed cancer in women worldwide, and survivors account for 40% of female cancer survivors. Genetic testing can influence care of both breast cancer patients and their family members. Although changes in guidelines have led to an increase in newly diagnosed breast cancer patients who are eligible for testing, many survivors have not had testing. This retrospective review was conducted to evaluate rates of and barriers to genetic testing in patients at an urban breast cancer survivorship center. As obstetrician–gynecologists are often the primary health care professionals for many patients, this information can be important for continued care of individuals and their families. METHODS: Patients seen in Montefiore Einstein Comprehensive Cancer Center breast survivorship program from January to December 2023 were analyzed for demographic features, referral to and results of genetic testing, and personal/family history of cancer. RESULTS: Two hundred eleven patients were seen. All patients were at least 5 years from initial breast cancer diagnosis. Only 77 patients had been referred to genetic counseling (34 at time of diagnosis or within 1 year). Of the 77 referred patients, 67 completed genetic counseling, and 55 accepted genetic testing. Of 12 patients who declined genetic testing, three cited financial barriers as their reason for declining. CONCLUSIONS/IMPLICATIONS: This study serves to inform on the current landscape of genetic testing among cancer survivors in an urban population and provides evidence for gynecologic and primary care teams routinely referring these patients for genetic counseling as part of continued care.